Ensign Peak Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Ensign Peak Advisors's VCYT Position: Q2 2026 in Review
Ensign Peak Advisors reduced its Veracyte (VCYT) stake by 13% in Q2 2026, selling an estimated $29.4K and leaving 4,515 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1232.
Ensign Peak Advisors first reported a position in VCYT in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.74M in Q3 2022. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Ensign Peak Advisors held 4,515 shares of Veracyte worth $265K as of Q2 2026.
- Ensign Peak Advisors sold 700 Veracyte shares in Q2 2026, an estimated $29.4K.
- Veracyte made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1232 holding.
- Ensign Peak Advisors first reported a position in Veracyte in Q4 2021 and has held it in 19 quarters since.
- Ensign Peak Advisors's Veracyte position peaked at $1.74M in Q3 2022.
- 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.